advanced search
Christopher Hirst
Head of RPH Pharmaceuticals
Recipharm

Is this your profile?

About

Christopher Hirst is Head of RPH Pharmaceuticals AB, a subsidiary of Stockholm-headquartered CDMO Recipharm AB. Mr Hirst has held business development and commercial roles at Recipharm, with a focus on generic and value-added medicines.

Contributions

EXPERT VIEW
PREVENTION NOT CURE: AVOIDING A EUROPEAN PRESCRIPTION OPIOID EPIDEMIC
Damon Smith, Richard Dart and Christopher Hirst discuss the causes and possible solutions to the prescription opioid epidemic, as well as whether or not Europe is likely to face a similar fate.
Top